Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoropyrimidine-mediated changes in small nuclear RNA.

R D Armstrong, C H Takimoto, E C Cadman

    The Journal of Biological Chemistry
    |January 5, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Macrophage 'Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same author

    Flea (Ctenocephalides felis) control efficacy of topical indoxacarb on dogs subsequently bathed with a chlorhexidine-ketoconazole shampoo.

    Australian veterinary journal·2015
    Same author

    Translation of anticancer efficacy from nonclinical models to the clinic.

    CPT: pharmacometrics & systems pharmacology·2014
    Same author

    Pharmacokinetic-pharmacodynamic integration of orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration.

    Journal of veterinary pharmacology and therapeutics·2010
    Same author

    Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients.

    Cancer chemotherapy and pharmacology·2010
    Same author

    Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients.

    Cancer chemotherapy and pharmacology·2009
    Same journal

    Wanted and unwanted modifications of mRNA, and their effect on gene expression and signaling.

    The Journal of biological chemistry·2026
    Same journal

    TGF-β2 drives lipid droplet accumulation in chondrocytes through the TβRI/p-Smad3/Fabp5 axis.

    The Journal of biological chemistry·2026
    Same journal

    Macrophage-specific targeting of histone demethylases with small-molecule inhibitors suppresses inflammatory response in vivo.

    The Journal of biological chemistry·2026
    Same journal

    Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.

    The Journal of biological chemistry·2026
    Same journal

    Correction: Characterization of Mast2 kinase defines structural features, regulation, and substrates.

    The Journal of biological chemistry·2026
    Same journal

    Isotope-Edited ESEEM: A New Method for Probing Copper Binding Sites in Neurodegenerative Proteins.

    The Journal of biological chemistry·2026
    See all related articles

    The antineoplastic agent 5-Fluorouridine (FUrd) alters small nuclear RNA (snRNA) metabolism in tumor cells. FUrd causes structural changes in U4/U6 snRNA and reduces U1 snRNA turnover, potentially impacting cytotoxicity.

    Area of Science:

    • Molecular Biology
    • Cancer Research
    • Biochemistry

    Background:

    • Small molecular weight nuclear RNA (snRNA) plays crucial roles in RNA processing.
    • Antineoplastic agents, such as 5-Fluorouridine (FUrd), can interfere with cellular metabolism.
    • Understanding FUrd's impact on snRNA is important for cancer therapy.

    Purpose of the Study:

    • To investigate the effects of 5-Fluorouridine (FUrd) on the metabolism of small molecular weight nuclear RNA (snRNA).
    • To determine how FUrd influences snRNA structure and turnover in cultured tumor cells.

    Main Methods:

    • Cultured Sarcoma-180 murine tumor cells were treated with FUrd and [3H]cytidine.
    • RNA was isolated at various time points (0, 24, 48 hours) post-treatment.
    • Electrophoretic analysis was performed using both nondenaturing and denaturing polyacrylamide gels.

    Related Experiment Videos

    Main Results:

    • FUrd induced dose-dependent alterations in snRNA metabolism.
    • Structural changes in U4 and U6 snRNA were observed, suggesting incorporation of 5-fluorouracil into secondary structures.
    • A selective reduction in U1 snRNA turnover was noted, with levels significantly elevated compared to controls at 48 hours post-treatment with 10 microM FUrd.

    Conclusions:

    • FUrd significantly impacts snRNA metabolism, including structural modifications and altered turnover rates.
    • These snRNA alterations may contribute to the known effects of FUrd on large molecular weight RNA metabolism and overall cytotoxicity.
    • The findings provide insights into the mechanisms of action for FUrd as an antineoplastic agent.